Table 2. Baseline MRI T2, T1 and Gd-enhancing lesion assessments.
| Patients n = 23 | HCs n = 15 | |
| T2 lesions | ||
| Number, mean (SD) | 34.9 (24.51) | 0.8 (1.37) |
| Median (range) | 28 (5–115) | 0 (0–4) |
| Volume, mm3, mean (SD) | 23683 (27731) | 57 (151) |
| Median (range) | 17739 (558–118940) | 0 (0–588) |
| T1 lesions | ||
| Number, mean (SD) | 19.5 (15.34) | 0 (0) |
| Median (range) | 19 (0–59) | 0 (−) |
| Volume, mm3, mean (SD) | 4532 (5417) | 0 (0) |
| Median (range) | 2847 (0–23364) | 0 (−) |
| Gd-enhancing lesions | ||
| Number, mean (SD) | 1.8 (4.84) | – |
| Median (range) | 0 (0–22) | – |
| Volume, mm3, mean (SD) | 240 (646) | – |
| Median (range) | 0 (0–2915) | – |
| Patient ID #/number of lesions | ||
| 29 | 22 | |
| 03 | 9 | |
| 22 | 4 | |
| 13, 23 | 2 | |
| 07, 08, 18 | 1 | |
| All others | 0 | |
Gd, gadolinium; HC, healthy control; MRI, magnetic resonance imaging; SD, standard deviation.